• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一篇综述发现,在关于不良事件的综述中,方法存在异质性,报告也不充分。

A review found heterogeneous approaches and insufficient reporting in overviews on adverse events.

机构信息

Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University, Ostmerheimer Str. 200, 51109, Cologne, Germany.

Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University, Ostmerheimer Str. 200, 51109, Cologne, Germany; Institute for Medical Statistics, University Medical Center Göttingen, Germany.

出版信息

J Clin Epidemiol. 2022 Nov;151:104-112. doi: 10.1016/j.jclinepi.2022.08.004. Epub 2022 Aug 17.

DOI:10.1016/j.jclinepi.2022.08.004
PMID:35987405
Abstract

OBJECTIVES

To investigate reporting and methodological characteristics of overviews on adverse (drug-associated) events (AEs) of pharmacological interventions.

STUDY DESIGN AND SETTING

We searched MEDLINE, Embase, Epistemonikos, and the Cochrane Database of Systematic Reviews from inception to May 17, 2021 for overviews exclusively investigating AEs of pharmacological interventions. We extracted general, reporting, and methodological characteristics and analyzed data descriptively.

RESULTS

We included 27 overviews, 70% of which were published in 2016 or later. The most common nomenclature in the title was "overview" (56%), followed by "umbrella review" (26%). The median number of included systematic reviews (SRs) in each overview was 15 (interquartile range 7-34). Study selection methods were reported in 52%, methods for data extraction in 67%, and methods for critical appraisal in 63% of overviews. An assessment of methodological quality of included SRs was performed in 70% of overviews. Only 22% of overviews reported strategies for dealing with overlapping SRs. An assessment of the certainty of the evidence was performed in 33% of overviews.

CONCLUSION

To ensure methodological rigor, authors of overviews on AEs should follow available guidance for the conduct and reporting of overviews.

摘要

目的

调查药物相关不良事件(AE)的药理学干预综合报告的报告和方法学特征。

研究设计和设置

我们检索了 MEDLINE、Embase、Epistemonikos 和 Cochrane 系统评价数据库,从建库到 2021 年 5 月 17 日,专门检索药理学干预药物不良事件的综合报告。我们提取了一般、报告和方法学特征,并进行了描述性数据分析。

结果

我们纳入了 27 篇综述,其中 70%的综述发表于 2016 年或之后。标题中最常见的命名法是“综述”(56%),其次是“伞状综述”(26%)。每篇综述纳入的系统评价(SR)中位数为 15 项(四分位距 7-34)。52%的综述报告了研究选择方法,67%的综述报告了数据提取方法,63%的综述报告了关键评估方法。70%的综述对纳入的 SR 进行了方法学质量评估。只有 22%的综述报告了处理重叠 SR 的策略。33%的综述对证据的确定性进行了评估。

结论

为了确保方法学严谨性,AE 综合报告的作者应遵循现有的综合报告指南。

相似文献

1
A review found heterogeneous approaches and insufficient reporting in overviews on adverse events.一篇综述发现,在关于不良事件的综述中,方法存在异质性,报告也不充分。
J Clin Epidemiol. 2022 Nov;151:104-112. doi: 10.1016/j.jclinepi.2022.08.004. Epub 2022 Aug 17.
2
Overviews of reviews in the cardiovascular field underreported critical methodological and transparency characteristics: a methodological study based on the Preferred Reporting Items for Overviews of Reviews (PRIOR) statement.心血管领域综述的概述报告了关键方法学和透明度特征:一项基于综述首选报告条目(PRIOR)声明的方法学研究。
J Clin Epidemiol. 2023 Jul;159:139-150. doi: 10.1016/j.jclinepi.2023.05.018. Epub 2023 May 26.
3
What guidance is available for researchers conducting overviews of reviews of healthcare interventions? A scoping review and qualitative metasummary.对于开展医疗保健干预措施综述的研究者,有哪些可用的指南?一项范围综述和定性元总结。
Syst Rev. 2016 Nov 14;5(1):190. doi: 10.1186/s13643-016-0367-5.
4
Appraisal methods and outcomes of AMSTAR 2 assessments in overviews of systematic reviews of interventions in the cardiovascular field: A methodological study.心血管领域干预措施系统评价概述中AMSTAR 2评估的评价方法与结果:一项方法学研究
Res Synth Methods. 2024 Mar;15(2):213-226. doi: 10.1002/jrsm.1680. Epub 2023 Nov 13.
5
Overviews of reviews often have limited rigor: a systematic review.综述的概述通常严谨性有限:系统综述。
J Clin Epidemiol. 2012 Dec;65(12):1267-73. doi: 10.1016/j.jclinepi.2012.06.015. Epub 2012 Sep 6.
6
Clinical utility of overviews on adverse events of pharmacological interventions.药物干预不良事件概述的临床实用性。
Syst Rev. 2023 Jul 31;12(1):131. doi: 10.1186/s13643-023-02289-z.
7
Overviews of reviews incompletely report methods for handling overlapping, discordant, and problematic data.综述对处理重叠、不一致和有问题的数据的方法报告不完整。
J Clin Epidemiol. 2020 Feb;118:69-85. doi: 10.1016/j.jclinepi.2019.09.025. Epub 2019 Oct 10.
8
The impact of different inclusion decisions on the comprehensiveness and complexity of overviews of reviews of healthcare interventions.不同纳入决策对医疗干预措施系统评价概述的全面性和复杂性的影响。
Syst Rev. 2019 Jan 11;8(1):18. doi: 10.1186/s13643-018-0914-3.
9
A descriptive analysis of overviews of reviews published between 2000 and 2011.对 2000 年至 2011 年发表的综述概述进行描述性分析。
PLoS One. 2012;7(11):e49667. doi: 10.1371/journal.pone.0049667. Epub 2012 Nov 15.
10
Epidemiology and reporting characteristics of overviews of reviews of healthcare interventions published 2012-2016: protocol for a systematic review.2012 - 2016年发表的医疗保健干预措施综述的流行病学及报告特征:一项系统综述方案
Syst Rev. 2017 Apr 7;6(1):73. doi: 10.1186/s13643-017-0468-9.

引用本文的文献

1
Evidence-informed and consensus-based statements about SAFEty of Physical Agent Modalities Practice in physiotherapy and rehabilitation medicine (SAFE PAMP): a national Delphi of healthcare scientific societies.关于物理治疗和康复医学中物理因子疗法安全性的循证和共识声明(SAFE PAMP):国家医疗保健科学学会德尔菲共识研究。
BMJ Open. 2024 Mar 19;14(3):e075348. doi: 10.1136/bmjopen-2023-075348.
2
Clinical utility of overviews on adverse events of pharmacological interventions.药物干预不良事件概述的临床实用性。
Syst Rev. 2023 Jul 31;12(1):131. doi: 10.1186/s13643-023-02289-z.
3
What is the landscape of evidence about the safety of physical agents used in physical medicine and rehabilitation? A scoping review.
物理医学与康复中使用的物理因子的安全性的证据现状如何? 范围综述。
BMJ Open. 2023 Jun 23;13(6):e068134. doi: 10.1136/bmjopen-2022-068134.